Media headlines about Nanosphere (NASDAQ:NSPH) have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Nanosphere earned a daily sentiment score of 0.10 on Accern’s scale. Accern also gave media coverage about the medical research company an impact score of 46.4162760707412 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

TRADEMARK VIOLATION NOTICE: “Nanosphere (NSPH) Earns Daily Media Impact Score of 0.10” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/03/nanosphere-nsph-earns-daily-media-impact-score-of-0-10.html.

About Nanosphere

Nanosphere, Inc is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing.

Insider Buying and Selling by Quarter for Nanosphere (NASDAQ:NSPH)

Receive News & Stock Ratings for Nanosphere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanosphere Inc. and related stocks with our FREE daily email newsletter.